Pear Therapeutics

Christopher Guiffre

J.D., M.B.A.

Chris is our CFO & COO. Before joining Pear, he served as President & Chief Executive Officer of Cerulean Pharma. He previously served as Cerulean’s Chief Operating Officer and before that as its Senior Vice President and Chief Business Officer. Prior to that, he held a number of senior executive positions at various biopharmaceutical companies, including President & Chief Executive Officer of Alvos Therapeutics, Inc., Chief Business Officer at Hydra Biosciences, Inc., and Senior Vice President, General Counsel and Secretary at Cubist Pharmaceuticals, Inc. Mr. Guiffre has also held several positions at Renaissance Worldwide, Inc., including Vice President, General Counsel and Clerk. Prior to that, he was an Associate at Bingham, Dana & Gould LLP (now known as Morgan, Lewis & Bockius LLP).

Mr. Guiffre received a B.S. from Babson College, a J.D. from Boston College Law School, and an M.B.A. from Boston College Carroll School of Management.